QURE
QURE
NASDAQ · Biotechnology

Uniqure Nv

$27.66
+3.51 (+14.53%)
As of May 9, 1:34 AM ET ·
Financial Highlights (FY 2026)
Revenue
15.31M
Net Income
-189,194,203
Gross Margin
89.5%
Profit Margin
-1,236.0%
Rev Growth
-46.7%
D/E Ratio
2.63
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 89.5% 89.5% 45.0% 45.0%
Operating Margin -1,151.4% -1,036.2% 12.4% 10.9%
Profit Margin -1,236.0% -1,174.2% 12.0% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.31M 28.74M 366.27M 316.03M
Gross Profit 13.71M 25.73M 164.91M 142.29M
Operating Income -176,271,994 -297,812,642 45.48M 34.44M
Net Income -189,194,203 -319,644,795 43.81M 38.10M
Gross Margin 89.5% 89.5% 45.0% 45.0%
Operating Margin -1,151.4% -1,036.2% 12.4% 10.9%
Profit Margin -1,236.0% -1,174.2% 12.0% 12.1%
Rev Growth -46.7% -46.7% -4.9% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 547.81M 547.81M 204.81M 207.31M
Total Equity 208.38M 208.38M 806.10M 940.40M
D/E Ratio 2.63 2.63 0.25 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -151,838,709 -270,784,256 53.48M 50.33M
Free Cash Flow 19.66M 18.73M